← Return to Keytruda, an immunotherapy drug, is shrinking the Merkel Cell tumors
DiscussionKeytruda, an immunotherapy drug, is shrinking the Merkel Cell tumors
Neuroendocrine Tumors (NETs) | Last Active: Jul 25, 2023 | Replies (14)Comment receiving replies
Replies to "Merck the maker of Keytruda and Moderna the maker of mRNA vaccines are in partnership. They..."
Thank you for the link. It appears that they are trying to turn cold tumors hot so they are more likely to respond to immune therapy. See “Nature” journal article on turning cold tumors hot with ivermectin in treatment resistant triple negative breast cancer.